The EU project RADOV held its second annual meeting at the KTH Royal Institute of Technology in Stockholm, Sweden, on September 25, 2024, after completing the second year of project implementation. Fifteen participants from four countries, representing institutions and companies involved in RADOV, convened to discuss the results achieved in the first two years of the project and to plan activities for the upcoming year. The event was organized in a hybrid format.

During the meeting, the six work packages (WPs) and their 19 associated tasks were presented and discussed. A Steering Committee (SC) meeting was also held. The intensive experimental work conducted during the first two years of RADOV led to the irradiation of 900 samples using gamma rays and electron beams. This research aimed to study the effects of irradiation conditions on protein fragmentation and the bioactive properties of irradiated materials. The investigation focused on various irradiation factors, including dose, dose rate, physical state, and atmosphere, specifically for three egg-derived proteins: lysozyme, ovotransferrin, ovalbumin and egg white.

Additionally, two products—a hydrogel wound dressing and packaging foil that contain bioactive proteins or peptides—are being developed simultaneously. Preliminary results from the scaling-up phase of these selected products are promising.

In addition to scientific discussions, topics such as project management, communication, dissemination activities, and formal and financial aspects of RADOV were also addressed. The activities of the Innovation and Quality Management Board (IQMB), which supports the research team in effectively transferring know-how and selecting products and technologies for further development, were reported. The event concluded with the Steering Committee meeting

Acknowledgement
This project has received funding from the European Union’s Euratom Research and Training Programme (EURATOM) Horizon Europe under Grant Agreement No 101061694